{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T01:22:12Z","timestamp":1768699332707,"version":"3.49.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"am","delay-in-days":274,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Fondation Jerome Lejeune"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/j.mehy.2019.109289","type":"journal-article","created":{"date-parts":[[2019,6,26]],"date-time":"2019-06-26T11:57:13Z","timestamp":1561550233000},"page":"109289","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Mental retardation in Down syndrome: Two ways to treat"],"prefix":"10.1016","volume":"131","author":[{"given":"Pierre P.","family":"Kamoun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2019.109289_b0005","series-title":"Developmental Landmarks for children with Down syndrome","author":"Share","year":"1974"},{"key":"10.1016\/j.mehy.2019.109289_b0010","first-page":"247","article-title":"Development and distribution of intellectual and adaptive skills in Down syndrome children: implications for early intervention","volume":"17","author":"Morgan","year":"1979","journal-title":"Mental Retard"},{"key":"10.1016\/j.mehy.2019.109289_b0015","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1054\/mehy.2001.1377","article-title":"Mental retardation in Down syndrome: a hydrogen sulfide hypothesis","volume":"57","author":"Kamoun","year":"2001","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.mehy.2019.109289_b0020","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0006-291X(85)91641-9","article-title":"Cystathionine beta synthase: gene dosage effect in trisomie 21","volume":"128","author":"Chadefaux","year":"1985","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.mehy.2019.109289_b0025","first-page":"1393","article-title":"Expression of chromosome 21-localized genes in acute myeloid leukemia: differences between Down and non-Down syndrome blast cells and relationship to in vitro sensitivity to cytosine arabinoside and daunorubicin","volume":"94","author":"Taub","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.mehy.2019.109289_b0030","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/00001756-200004070-00044","article-title":"Polymorphism of genes controlling homocysteine\/folate metabolism and cognitive function","volume":"11","author":"Barbaux","year":"2000","journal-title":"NeuroReport"},{"key":"10.1016\/j.mehy.2019.109289_b0035","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.bbrc.2005.10.118","article-title":"Cystathionine beta-synthase is enriched in the brains of Down\u2019s patients","volume":"338","author":"Ichinohe","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.mehy.2019.109289_b0040","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1385\/MN:26:1:013","article-title":"Hydrogen sulfide as a neuromodulator","volume":"26","author":"Kimura","year":"2002","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.mehy.2019.109289_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.01.072","article-title":"Role of hydrogen sulfide in cognitive deficits: evidences and mechanisms","author":"He","year":"2019","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.mehy.2019.109289_b0050","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/978-3-319-18144-8_3","article-title":"Physiological roles of hydrogen sulfide and polysulfides","volume":"230","author":"Kimura","year":"2015","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.mehy.2019.109289_b0055","article-title":"Signaling by hydrogen sulfide and polysulfides via protein S-sulfuration","author":"Kimura","year":"2019","journal-title":"Br J Pharmacol."},{"key":"10.1016\/j.mehy.2019.109289_b0060","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00726-004-0072-x","article-title":"Endogenous production of hydrogen sulfide in mammals","volume":"26","author":"Kamoun","year":"2004","journal-title":"Amino Acids"},{"key":"10.1016\/j.mehy.2019.109289_b0065","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1089\/ars.2008.2253","article-title":"3-mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain","volume":"11","author":"Shibuya","year":"2009","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.mehy.2019.109289_b0070","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.1038\/srep14774","article-title":"Identification of H2S3 and H2S produced by 3-mercaptopyruvate sulfurtransferase in the brain","volume":"5","author":"Kimura","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.mehy.2019.109289_b0075","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.legalmed.2016.12.004","article-title":"Liquid chromatography-tandem mass spectrometry method for the determination of thiosulfate in human blood and urine as an indicator of hydrogen sulfide poisoning","volume":"24","author":"Maseda","year":"2017","journal-title":"Leg Med"},{"key":"10.1016\/j.mehy.2019.109289_b0080","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1080\/00365517809108814","article-title":"Determination of thiosulphate in urine","volume":"38","author":"Sorbo","year":"1978","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/j.mehy.2019.109289_b0085","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0009-8981(87)90101-X","article-title":"Urinary thiosulphate as an indicator of exposure to hydrogen sulphide vapor","volume":"164","author":"Kangas","year":"1987","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.mehy.2019.109289_b0090","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1093\/clinchem\/47.8.1500","article-title":"Urinary sulfur compounds in Down syndrome","volume":"47","author":"Bellardinelli","year":"2001","journal-title":"Clin Chem"},{"key":"10.1016\/j.mehy.2019.109289_b0095","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/ajmg.a.10847","article-title":"Endogenous hydrogen sulfide overproduction in Down syndrome","volume":"116A","author":"Kamoun","year":"2003","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.mehy.2019.109289_b0100","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1001\/archneur.1997.00550140077016","article-title":"Cerebellar volume in adults with Down syndrome","volume":"54","author":"Aylward","year":"1997","journal-title":"Arch Neurol"},{"key":"10.1016\/j.mehy.2019.109289_b0105","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0304-3940(91)90864-P","article-title":"Chronic exposure to low concentrations of hydrogen sulfide produces abnormal growth in developing cerebellar Purkinje cells","volume":"122","author":"Hannah","year":"1991","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.mehy.2019.109289_b0110","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1096\/fj.05-3724fje","article-title":"Cystathionine beta-synthase, a key enzyme for homocysteine metabolism, is preferentially expressed in the radial glia\/astrocyte lineage of developing mouse CNS","volume":"19","author":"Enokido","year":"2005","journal-title":"FASEB J"},{"key":"10.1016\/j.mehy.2019.109289_b0115","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ymgme.2017.05.011","article-title":"Cystathionine beta synthase deficiency: og mice and man","volume":"121","author":"Kruger","year":"2017","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.mehy.2019.109289_b0120","unstructured":"Mudd SH, Levy HL, Skovby F. Disorders of transsulfuration. In: Scriver CR, Beaudet AL, Sly WS, Valle D (editors). The metabolic and molecular bases of inherited disease. Vol. 1 (7th ed.) New York: McGraw-Hill (pub) 1995. p. 1279\u20131327."},{"key":"10.1016\/j.mehy.2019.109289_b0125","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddy447","article-title":"Cbs overdosage is necessary and sufficient to induce cognitive phenotypes in mouse models of Down syndrome and interacts genetically with Dyrk1 a","author":"Marechal","year":"2019","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.mehy.2019.109289_b0130","article-title":"Cystathionine beta synthase in Physiology and Cancer","author":"Zhu","year":"2018","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.mehy.2019.109289_b0135","first-page":"881","article-title":"Trial of amino-oxyacetic, an anticonvulsivant","volume":"88","author":"Tibbles","year":"1963","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.mehy.2019.109289_b0140","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.4103\/1673-5374.237120","article-title":"Aminooxyacetic acid improves learning and memory in a rat model of chronic alcoholism","volume":"13","author":"Du","year":"2018","journal-title":"Neural Regen Res"},{"issue":"Pt A","key":"10.1016\/j.mehy.2019.109289_b0145","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.phrs.2016.08.016","volume":"113","author":"Druzhyna","year":"2016","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.mehy.2019.109289_b0150","first-page":"2409","article-title":"The effect of levodopa benserazide hydrochloride levels in patients with Parkinson\u2019s disease and treatment of hyperhomocysteinemia","volume":"20","author":"Guo","year":"2016","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.mehy.2019.109289_b0155","doi-asserted-by":"crossref","unstructured":"Kiese M, Weger N. Formation of ferrihaemoglobin with aminophenols in the human for the treatment of cyanide poisoning. 1969;7:97\u2013105.","DOI":"10.1016\/0014-2999(69)90170-8"},{"key":"10.1016\/j.mehy.2019.109289_b0160","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0304-4165(68)90108-6","article-title":"Mechanism of formation of sulphhaemoglobin","volume":"156","author":"Nichol","year":"1968","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.mehy.2019.109289_b0165","doi-asserted-by":"crossref","first-page":"45995","DOI":"10.1038\/srep45995","article-title":"Polysulfides (H2Sn) produced from the interaction of hydrogen sulfide (H2S) and nitric oxide (NO) activate TRPA1 channels","volume":"7","author":"Miyamoto","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.mehy.2019.109289_b0170","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.bcp.2018.01.045","article-title":"Investigations on the role of hemoglobin in sulfide metabolism by intact red blood cells","volume":"149","author":"Bianco","year":"2018","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.mehy.2019.109289_b0175","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1161\/CIRCULATIONAHA.107.753814","article-title":"Therapeutic uses of inorganic nitrite and nitrate: from the past to the future","volume":"117","author":"Butler","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.mehy.2019.109289_b0180","doi-asserted-by":"crossref","DOI":"10.1089\/dia.2011.0291","article-title":"Single-dose pharmacokinetics of different oral sodium nitrite formulations in diabetes patients","volume":"14","author":"Greenway","year":"2012","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.mehy.2019.109289_b0185","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1002\/ejic.201402082","article-title":"Kinetics and mechanism of the reaction of hydrogen sulfide with diaquacobinamide in aqueous solution","author":"Salnikov","year":"2014","journal-title":"Eur J Inorg Chem 2014"},{"key":"10.1016\/j.mehy.2019.109289_b0190","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3109\/15563650.2014.904045","article-title":"The vitamin B12 analog cobinamide is an effective hydrogen sulfide antidote in a lethal rabbit model","volume":"52","author":"Brenner","year":"2014","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.mehy.2019.109289_b0195","doi-asserted-by":"crossref","first-page":"20831","DOI":"10.1038\/srep20831","article-title":"Hydrogen sulfide-Mechanism of toxicity and development of an antidote","volume":"6","author":"Jiang","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.mehy.2019.109289_b0200","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/nyas.13559","article-title":"Cobinamide is effective for treatment of hydrogen sulfide-induced neurological sequelae in a mouse model","volume":"1408","author":"Anantharam","year":"2017","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.mehy.2019.109289_b0205","doi-asserted-by":"crossref","unstructured":"Boss GR. (personal communication) February 2019.","DOI":"10.5465\/AMBPP.2019.18915abstract"},{"key":"10.1016\/j.mehy.2019.109289_b0210","first-page":"4570","article-title":"Three-wavelength method for the optical differentiation of methemoglobin and sulfhemoglobin in oxygenated blood","volume":"2017","author":"Van Leeuwen","year":"2017","journal-title":"Conf Proc IEEE Eng Med Biol Soc"},{"key":"10.1016\/j.mehy.2019.109289_b0215","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.tox.2007.09.009","article-title":"Prevention of hydrogen sulfide (H2S)-induced mouse lethality and cytotoxicity by hydroxocobalamin (vitamin B12a)","volume":"242","author":"Truong","year":"2007","journal-title":"Toxicology"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987719303639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987719303639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:14:50Z","timestamp":1759691690000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987719303639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":43,"alternative-id":["S0306987719303639"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2019.109289","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mental retardation in Down syndrome: Two ways to treat","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2019.109289","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109289"}}